Reaction Details Report a problem with these data
Target
Mitogen-activated protein kinase 1
Ligand
BDBM365061
Substrate
n/a
Meas. Tech.
Enzymatic Assay
IC50
1.12±n/a nM
Citation
 Kolesnikov, A; Do, S Serine/threonine kinase inhibitors US Patent  US9867833 Publication Date 1/16/2018 
Target
Name:
Mitogen-activated protein kinase 1
Synonyms:
ERK2 | ERT1 | Extracellular signal-regulated kinase 2 | Extracellular signal-regulated kinase 2 (ERK-2) | Extracellular signal-regulated kinase 2 (ERK2) | MAP Kinase 2/ERK2 | MAPK 2 | MAPK1 | MK01_HUMAN | Mitogen activated kinase 1 (ERK-2) | Mitogen-activated protein kinase 1 (ERK-2) | Mitogen-activated protein kinase 1 (ERK2) | Mitogen-activated protein kinase 2 | PRKM1 | PRKM2 | p42-MAPK
Type:
Ser/Thr Protein Kinase
Mol. Mass.:
41392.76
Organism:
Homo sapiens (Human)
Description:
P28482
Residue:
360
Sequence:
MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS
  
Inhibitor
Name:
BDBM365061
Synonyms:
(R)-9-isobutyl-8-methyl-4-(2- ((1-methyl-1H-pyrazol-5- yl)amino)pyrimidin-4-yl)-8,9- dihydro-1,2,2a1,6,8- pentaazabenzo[cd]azulen- 7(6H)-one | US10278975, Compound I-23 | US10517878, Compound I-23 | US10842799, I-23 | US11376260, Example I-23 | US9867833, Compound I-23
Type:
Small organic molecule
Emp. Form.:
C21H24N10O
Mol. Mass.:
432.4817
SMILES:
CC(C)C[C@H]1N(C)C(=O)Nc2cc(cc3nnc1n23)-c1ccnc(Nc2ccnn2C)n1 |r|
Structure:
Search PDB for entries with ligand similarity: